Grifols SA (GRFS) stock
GRFSNasdaqPharmaceutical PreparationsAlso trades as GIFLF, GIFOF, GIKLY
$8.47−0.16 (-1.85%)
Close on Nov 18, 2026Market cap $2.91BP/E 6.5Yield –
Grifols free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
For fiscal 2025 it was €782.00M, up 16.9% from the year before. Over ten years it grew 13.5% a year on average. The highest annual figure on record is €830.18M in fiscal 2020.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | €782.00M | +16.9% |
| FY2024 | Dec 31, 2024 | €669.00M | – |
| FY2023 | Dec 31, 2023 | -€7.00M | – |
| FY2022 | Dec 31, 2022 | -€285.23M | -181.6% |
| FY2021 | Dec 31, 2021 | €349.60M | -57.9% |
| FY2020 | Dec 31, 2020 | €830.18M | +221.1% |
| FY2019 | Dec 31, 2019 | €258.55M | -48.8% |
| FY2018 | Dec 31, 2018 | €505.45M | -14.4% |
| FY2017 | Dec 31, 2017 | €590.24M | +94.2% |
| FY2016 | Dec 31, 2016 | €303.86M | +38.0% |
| FY2015 | Dec 31, 2015 | €220.19M | – |
See a number that looks wrong?